Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy
Fieke W. Hoff(University Medical Center Groningen), Yazan F. Madanat(The University of Texas Southwestern Medical Center), Elie Traer(Memorial Sloan Kettering Cancer Center), Wendy Stock(University of Chicago), Michael W. Deininger(Versiti Blood Center of Wisconsin), Kristin L Koenig(The Ohio State University), Uma Borate(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Vu H. Duong(University of Maryland, Baltimore), Martha Arellano(Memorial Sloan Kettering Cancer Center), Alice S. Mims(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Ying Huang(The Ohio State University), Ronan Swords(University of Miami), Brian Druker(Oregon Health & Science University), Mona Stefanos(The Ohio State University), James M. Foran(Memorial Sloan Kettering Cancer Center), Tara L. Lin(Dana-Farber Cancer Institute), Gary J. Schiller(Fred Hutch Cancer Center), Robert L. Redner(UPMC Hillman Cancer Center), Molly Martycz(The Ohio State University), Joshua F. Zeidner(University of North Carolina at Chapel Hill), Maria R. Baer(University of Maryland, Baltimore), Timothy L. Chen(The Ohio State University), Olatoyosi Odenike(University of Chicago), Ashley O. Yocum(Leukemia and Lymphoma Society), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Prapti A. Patel(The University of Texas Southwestern Medical Center), Rebecca L. Olin(University of California, San Francisco), Kellie J. Archer(The Ohio State University), Leonard Rosenberg(Leukemia and Lymphoma Society), Amy Burd(Leukemia and Lymphoma Society), Robert H. Collins(Texas Oncology), Emily Curran(University of Cincinnati), Catherine C. Smith(University of California, San Francisco), Rina Li Welkie(The Ohio State University), Nyla A. Heerema(The Ohio State University), John C. Byrd(University of Cincinnati), Tibor Kovacsovics(Hôpital Edouard Herriot), William Blum(The Ohio State University)
Cited by 29
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k